Fig. 2: Mean left ventricular ejection fraction (mLVEF) over time according to treatment arm.

After a minor decrement from screening to week 13 (T + L arm: 64.5–62.5%, T arm: 64.5–62.8%, respectively), mLVEF becomes stable in both treatment arms until the end of treatment (T + L arm: 62.0%, T arm: 62.2%).